by Bruce Sylvester – Emerging uses of FDA approved drugs – Immunosuppresant drugs used to prevent organ rejection after transplantation could become used in fighting persistent HIV infection,… read more.
Enzyme’s role is to ‘throw away’ protein if it overstays its welcome during immune response. An enzyme that helps maintain immune system function by “throwing away” a specific… read more.
Maria Dalby reporting from the annual British Transplantation Society meeting in Glasgow by Anthony Dorling, King’s College London – Chronic rejection is a major cause of graft failure… read more.
A novel antiviral drug may protect people infected with the measles from getting sick and prevent them from spreading the virus to others, an international team of researchers… read more.
by Bruce Sylvester – Diflunisal, a generic anti-inflammatory drug, appears to reduce neurological decline and preserve quality-of-life in patients with familial transthyretin amyloidosis (ATTR).
Report from the Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. Length of infection increases risk for atherosclerosis. HIV infection, not antiretroviral therapy… read more.
by Bruce Sylvester – taken from The Lancet – An investigative, single-pill combination drug shows efficacy for treating patients with the most difficult-to-treat types of hepatitis C, researchers… read more.
Investigators reported on Oct. 22 in the Journal of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) that treatment with adalimumab may be effective for patients with steroid-resistant… read more.
Invasive microbial infections are a major cause of morbidity and mortality in organ transplantation patients. The satellite symposia sponsored by Astellas Pharma at ESOT 2013 discussed the challenge… read more.
by Bruce Sylvester – Investigators suggest caution in prescribing inhaled corticosteroids to high-risk patients such as pneumonia survivors, after their research shows a twofold risk for repeat infection.
Infections cause a lower proportion of lead extractions than expected, according to preliminary results from the ELECTRa Registry presented at ESC by Dr Maria Grazia Bongiorni from Italy.
‘Big 4’ Journal Highlights – Journal of the American Medical (JAMA) – by Bruce Sylvester -Among patients with unfavorable treatment characteristics, treating chronic hepatitis C virus (HCV) genotype… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
